+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Coronary Artery Bypass Grafts Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887530
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The coronary artery bypass grafts market is evolving rapidly as clinical practices adapt, emerging technologies mature, and economic realities demand operational efficiency. Senior decision-makers face an increasingly complex landscape—balancing patient outcome imperatives, rising cost pressures, and the drive toward scalable innovation.

Market Snapshot: Coronary Artery Bypass Grafts Market

The global coronary artery bypass grafts market advanced from USD 20.89 billion in 2025 to USD 21.96 billion in 2026, with continued expansion forecast at a 5.24% CAGR. By 2032, projections indicate the market will reach USD 29.88 billion. This steady growth is driven by expanded adoption of minimally invasive and robotic procedures, renewed focus on operational optimization, and a shift in procurement strategies reflecting both clinical needs and fiscal discipline. Technology integration and an increased emphasis on patient-centric care models support long-term adoption, while competitive and regulatory factors create new challenges for established suppliers and innovators alike.

Scope & Segmentation of the Coronary Artery Bypass Grafts Market

This report delivers a detailed examination of the changing landscape in coronary artery bypass grafts, offering actionable insights into the primary areas influencing adoption, purchasing decisions, and operational models. Market segmentation addresses key dynamics affecting investment, technology selection, and commercial opportunity across all major stakeholders.

  • Graft Types: Adoption of arterial conduits is rising, given their extended durability, while venous grafts remain vital for patient-specific clinical needs and varied anatomical considerations.
  • Procedural Modalities: Analysis includes conventional on-pump, off-pump, and minimally invasive techniques, with robotic and endoscopic procedures gaining in strategic importance for recovery and workflow efficiency.
  • End-User Settings: Major end users span hospitals managing complex revascularization, specialized cardiac centers handling high volumes, and ambulatory surgical centers offering minimally invasive treatment.
  • Clinical Applications: Focus areas extend to single- and multi-vessel coronary artery disease management, with procedural selection influenced by case complexity, comorbidities, and required resource utilization.
  • Key Regions: Americas, EMEA (Europe, Middle East & Africa), and Asia-Pacific each present distinct drivers such as reimbursement structures, procedural preferences, and evolving regional regulations.
  • Technological Advancements: Innovations including less invasive conduit harvesting, improvements in graft procurement, robotic support systems, and enhanced imaging integration—coupled with perioperative data analytics—are accelerating clinical adoption and supporting operational performance.

Key Takeaways Shaping Strategic Decisions

  • Clinical priorities are shifting from focusing solely on procedural statistics to emphasizing holistic patient recovery and sustainable graft durability.
  • Minimally invasive and robotic-assisted procedures, once considered niche, are moving to the mainstream and setting new benchmarks for speed of recovery and utilization.
  • Integrated solutions that align medical devices, clinician upskilling, advanced analytics, and perioperative care optimization are increasingly expected by procurement teams and clinical leads.
  • Procurement and supply chain leaders face heightened due diligence in selecting vendors and strengthening sourcing resilience in response to market and policy-driven pressures.
  • Segment-centric strategies help manufacturers and distributors tailor product and service offerings, optimizing support across hospital, specialty, and ambulatory care environments.
  • Regional differences in regulatory oversight, clinical practice, and technology uptake require flexible commercialization plans and adaptive distribution models.

Tariff Impact on Surgical Ecosystem

The tariff measures imposed by the United States in 2025 brought fresh complexity to coronary artery bypass graft supply chains. Providers have responded by diversifying suppliers and seeking out new manufacturing partnerships, aiming to buffer immediate cost effects and safeguard operational continuity. Manufacturers are reassessing global production footprints to limit duty exposure, and hospitals are actively renegotiating contracts to favor bundled pricing and agreements linked to patient outcomes. These trends are fast-tracking a new alignment of commercial and clinical strategies that prioritize sustained access, value, and transparent risk-sharing between all stakeholders.

Methodology & Data Sources

The research in this report integrates secondary data from peer-reviewed publications, regulatory filings, and established market records, with primary insights from structured clinician and procurement leader interviews. Methodological rigor is achieved through data triangulation, scenario-based validation, and review by industry experts, ensuring reliability and relevance of the findings.

Why This Report Matters

  • Clarifies opportunities for investment and product portfolio development by mapping growth patterns and technological adoption within the coronary artery bypass grafts market.
  • Informs commercial decision-making by detailing regional market drivers, buyer behaviors, and exposure to procurement disruptions driven by supply chain risks.
  • Helps operational leaders optimize procedural implementation, allocate critical resources, and embed continuous innovation into care delivery workflows.

Conclusion

The coronary artery bypass grafts market continues to advance through clinical innovation, adaptive operations, and changing procurement landscapes. Access to timely, data-driven intelligence supports strategic leadership and sustained improvement for all engaged stakeholders.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Coronary Artery Bypass Grafts Market, by Graft Type
8.1. Arterial
8.2. Venous
9. Coronary Artery Bypass Grafts Market, by Procedure Type
9.1. Conventional On Pump
9.2. Minimally Invasive
9.2.1. Endoscopic
9.2.2. Robotic
9.3. Off Pump
10. Coronary Artery Bypass Grafts Market, by Application
10.1. Multi Vessel Disease
10.2. Single Vessel Disease
11. Coronary Artery Bypass Grafts Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Cardiac Centers
11.3. Hospitals
12. Coronary Artery Bypass Grafts Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Coronary Artery Bypass Grafts Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Coronary Artery Bypass Grafts Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Coronary Artery Bypass Grafts Market
16. China Coronary Artery Bypass Grafts Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AtriCure, Inc.
17.6. B. Braun Melsungen AG
17.7. Baxter International Inc.
17.8. ConMed Corporation
17.9. CryoLife, Inc.
17.10. Edwards Lifesciences Corporation
17.11. enVVeno Medical Corporation
17.12. Getinge AB
17.13. LivaNova PLC
17.14. Medtronic plc
17.15. Teleflex Incorporated
17.16. Terumo Corporation
17.17. Transonic Systems Inc.
17.18. Vascular Graft Solutions Ltd.
List of Figures
FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 45. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 46. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 52. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 58. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 70. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 71. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 72. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 76. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 83. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 84. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 95. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 96. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 97. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 101. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 102. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 103. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 113. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 114. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 115. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 119. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 120. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 121. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 125. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 126. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 127. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 131. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 132. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 138. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 139. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 140. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Coronary Artery Bypass Grafts market report include:
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • ConMed Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • enVVeno Medical Corporation
  • Getinge AB
  • LivaNova PLC
  • Medtronic plc
  • Teleflex Incorporated
  • Terumo Corporation
  • Transonic Systems Inc.
  • Vascular Graft Solutions Ltd.

Table Information